JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4501
Carlyle Secured Lending
CGBD
$722M
| $351K | ﹤0.01% |
25,750
+3,142
| +14% | +$46.3K |
2018 Q2
19 quarters
|
|
4502
Global X Cloud Computing ETF
CLOU
$383M
| $351K | ﹤0.01% |
19,114
-16,725
| -47% | -$292K |
2020 Q4
9 quarters
|
|
4503
Citi Trends
CTRN
$410M
| $350K | ﹤0.01% |
18,382
+1,299
| +8% | +$35.7K |
2016 Q2
27 quarters
|
|
|
VZLA
4504
Vizsla Silver
VZLA
$1.25B
| $350K | ﹤0.01% |
230,200
+67,800
| +42% | +$87.6K |
2022 Q1
4 quarters
|
|
|
BSCN
4505
DELISTED
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
| $350K | ﹤0.01% |
16,598
-140,844
| -89% | -$2.96M |
2018 Q1
20 quarters
|
|
4506
iRadimed
IRMD
$1.08B
| $349K | ﹤0.01% |
8,861
+4,783
| +117% | +$174K |
2016 Q3
26 quarters
|
|
4507
Miller Industries
MLR
$614M
| $348K | ﹤0.01% |
9,847
+1,084
| +12% | +$32.1K |
2017 Q4
21 quarters
|
|
|
CSSE
4508
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
| $348K | ﹤0.01% |
173,918
+173,433
| +35,759% | +$816K |
2021 Q2
7 quarters
|
|
4509
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
$1.41B
| $347K | ﹤0.01% |
12,837
-5,087
| -28% | -$139K |
2021 Q2
7 quarters
|
|
|
PDS
4510
Precision Drilling
PDS
$1.07B
| $347K | ﹤0.01% |
6,743
-33,111
| -83% | -$2.14M |
2017 Q3
22 quarters
|
|
4511
Latham Group
SWIM
$752M
| $345K | ﹤0.01% |
120,917
-92,655
| -43% | -$325K |
2021 Q2
7 quarters
|
|
4512
PUT
Tapestry
TPR
$23.3B
| $345K | ﹤0.01% |
8,000
+4,000
| +100% | +$172K |
2022 Q1
4 quarters
|
|
4513
CALL
Labcorp
LH
$25.3B
| $344K | ﹤0.01% |
+1,746
| New | +$359K |
2023 Q1
0 quarters
|
|
4514
Bank of Marin Bancorp
BMRC
$444M
| $341K | ﹤0.01% |
15,591
+5,821
| +60% | +$168K |
2014 Q1
36 quarters
|
|
4515
CALL
Centene
CNC
$31.9B
| $341K | ﹤0.01% |
5,400
-13,400
| -71% | -$951K |
2022 Q3
2 quarters
|
|
4516
Mirum Pharmaceuticals
MIRM
$5.15B
| $341K | ﹤0.01% |
14,203
-64,368
| -82% | -$1.47M |
2019 Q3
14 quarters
|
|
4517
Tiptree Inc
TIPT
$639M
| $341K | ﹤0.01% |
23,383
+3,765
| +19% | +$57.3K |
2017 Q4
21 quarters
|
|
|
GMDA
4518
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $341K | ﹤0.01% |
421,759
| – | – |
2020 Q4
9 quarters
|
|
4519
Timberland Bancorp
TSBK
$355M
| $340K | ﹤0.01% |
+12,577
| New | +$407K |
2023 Q1
0 quarters
|
|
4520
Butterfly Network
BFLY
$2.32B
| $339K | ﹤0.01% |
180,004
+32,231
| +22% | +$75.3K |
2021 Q1
8 quarters
|
|
|
ARCE
4521
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| $339K | ﹤0.01% |
30,980
-2,473
| -7% | -$31.8K |
2020 Q4
9 quarters
|
|
4522
Ocular Therapeutix
OCUL
$1.61B
| $337K | ﹤0.01% |
63,941
+17,838
| +39% | +$84.7K |
2017 Q1
24 quarters
|
|
4523
SEACOR Marine Holdings
SMHI
$227M
| $337K | ﹤0.01% |
44,296
+44,209
| +50,815% | +$420K |
2017 Q2
23 quarters
|
|
4524
iShares Global Consumer Discretionary ETF
RXI
$301M
| $337K | ﹤0.01% |
2,320
-634
| -21% | -$88.5K |
2018 Q1
20 quarters
|
|
4525
Instil Bio
TIL
$46.7M
| $336K | ﹤0.01% |
25,436
+721
| +3% | +$10.7K |
2021 Q1
8 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.